Minna Pöyhönen

6.6k citations

76 papers · 3.7k indexed · 1 hit paper · h-index 31

Neurology top 0.2%
Molecular Biology top 10%
Rheumatology top 1%
Physiology top 5%
Epidemiology top 5%

Co-authors: Hannu Kalimo Matti Viitanen Juha Peltonen Liisa Myllykangas Petra Pasanen Anders Paetau Sirkku Peltonen Maija Siitonen
Topics: Cerebrovascular and genetic disorders (23 papers)Neurofibromatosis and Schwannoma Cases (23 papers)Cell Adhesion Molecules Research (10 papers)
Cited by: Neurology Rheumatology
Journals: Nature Medicine Journal of Clinical Oncology Brain
Partner nations: Finland Sweden United States

In The Last Decade

Minna Pöyhönen

73 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A novel α-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson's disease-type pathology

2014 413 citations Petra Pasanen, Liisa Myllykangas et al. Neurobiology of Aging profile →

Peers

Countries citing papers authored by Minna Pöyhönen

Since Specialization

Citations

This map shows the geographic impact of Minna Pöyhönen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minna Pöyhönen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minna Pöyhönen more than expected).

Fields of papers citing papers by Minna Pöyhönen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minna Pöyhönen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minna Pöyhönen. The network helps show where Minna Pöyhönen may publish in the future.

Co-authorship network of co-authors of Minna Pöyhönen

This figure shows the co-authorship network connecting the top 25 collaborators of Minna Pöyhönen. A scholar is included among the top collaborators of Minna Pöyhönen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minna Pöyhönen. Minna Pöyhönen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Craniofacial and dental features of Axenfeld‐Rieger syndrome patients with PITX2 mutations 2023 ·Orthodontics and Craniofacial Research ·Sirpa Arte,Minna Pöyhönen,(unknown),(unknown),David Rice,Pekka Nieminen	4
2	Clinical features and spectrum of NOTCH3 variants in Finnish patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) 2022 ·Acta Neurologica Scandinavica ·(unknown),(unknown),Johanna Schleutker,Liisa Myllykangas,Minna Pöyhönen	6
3	APOE ε4 associates with increased risk of severe COVID-19, cerebral microhaemorrhages and post-COVID mental fatigue: a Finnish biobank, autopsy and clinical study 2021 ·Acta Neuropathologica Communications ·(unknown),Jonas Kantonen,Karri Kaivola,Laura Hokkanen,Mikko I. Mäyränpää,Henri Puttonen,(unknown),(unknown),Minna Pöyhönen,Mia Kero,Jarno Tuimala,Olli Carpén,(unknown),Olli Vapalahti,Marjaana Tiainen,Pentti J. Tienari,Kai Kaila,Johanna Hästbacka,Liisa Myllykangas	55
4	Constitutional mosaicism for a BRCA2 mutation as a cause of early-onset breast cancer 2020 ·Familial Cancer ·Pia Alhopuro,(unknown),Anna‐Kaisa Anttonen,Kristiina Aittomäki,Heli Nevanlinna,Minna Pöyhönen	11
5	Identification of OAF and PVRL1 as candidate genes for an ocular anomaly characterized by Peters anomaly type 2 and ectopia lentis 2018 ·Experimental Eye Research ·D. David,Deepti Anand,(unknown),Brian Gloss,(unknown),Marcel E. Dinger,Päivi Lindahl,Minna Pöyhönen,Hannele Laivuori,João Lavinha	5
6	Congenital anomalies in neurofibromatosis 1: a retrospective register-based total population study 2018 ·Orphanet Journal of Rare Diseases ·Jussi Leppävirta,Roope A. Kallionpää,Elina Uusitalo,Tero Vahlberg,Minna Pöyhönen,Juha Peltonen,Sirkku Peltonen	21
7	Genetics of dementia in a Finnish cohort 2018 ·European Journal of Human Genetics ·Petra Pasanen,Liisa Myllykangas,Minna Pöyhönen,(unknown),Maija Siitonen,John Hardy,José Brás,Anders Paetau,Pentti J. Tienari,Rita Guerreiro,Auli Verkkoniemi‐Ahola	7
8	008 Congenital anomalies in neurofibromatosis 1: A retrospective register-based total population study 2017 ·Journal of Investigative Dermatology ·Jussi Leppävirta,Roope A. Kallionpää,(unknown),Minna Pöyhönen,Juha Peltonen,Sirkku Peltonen	3
9	Prevalence of neurofibromatosis type 1 in the Finnish population 2017 ·Genetics in Medicine ·Roope A. Kallionpää,Elina Uusitalo,Jussi Leppävirta,Minna Pöyhönen,Sirkku Peltonen,Juha Peltonen	105
10	SNCA mutation p.Ala53Glu is derived from a common founder in the Finnish population 2016 ·Neurobiology of Aging ·Petra Pasanen,Eino Palin,(unknown),Minna Pöyhönen,Juha O. Rinne,Markku Päivärinta,Mika H. Martikainen,Valtteri Kaasinen,Marja Hietala,Maria Gardberg,Anna Maija Saukkonen,Johanna Eerola‐Rautio,Seppo Kaakkola,Jukka Lyytinen,Pentti J. Tienari,Anders Paetau,Anu Suomalainen,Liisa Myllykangas	8
11	Experimental studies of mitochondrial function in CADASIL vascular smooth muscle cells 2012 ·Experimental Cell Research ·Matti Viitanen,Erik Sundström,Marc Baumann,Minna Pöyhönen,Saara Tikka,Homira Behbahani	25
12	Loss of SUFU Function in Familial Multiple Meningioma 2012 ·The American Journal of Human Genetics ·Mervi Aavikko,(unknown),Silva Saarinen,Pia Alhopuro,Eevi Kaasinen,Ekaterina Morgunova,Yilong Li,(unknown),Miriam J. Smith,D. Gareth Evans,Minna Pöyhönen,Anne Kiuru,Anssi Auvinen,Lauri A. Aaltonen,Jussi Taipale,Pia Vahteristo	105
13	Molecular analysis of the CHD7 gene in CHARGE syndrome: identification of 22 novel mutations and evidence for a low contribution of large CHD7 deletions 2007 ·Genetics in Medicine ·(unknown),Sirpa Ala‐Mello,Carola Saloranta,Maila Penttinen,Minna Pöyhönen,Kirsi Huoponen,Wiktor Borozdin,Birke Bausch,Elke Botzenhart,Christian Wilhelm,Helena Kääriäinen,Jürgen Kohlhase	38
14	Mitochondrial DNA sequence variation and mutation rate in patients with CADASIL 2006 ·Neurogenetics ·(unknown),Saara Finnilä,Kati Mykkänen,Jukka S. Moilanen,Johanna Veijola,Minna Pöyhönen,Matti Viitanen,Hannu Kalimo,Kari Majamaa	14
15	Ophthalmologic Findings in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy 2006 ·Ophthalmology ·Susanna Roine,Mika Harju,Tero Kivelä,Minna Pöyhönen,Eeva Nikoskelainen,Seppo Tuisku,Hannu Kalimo,Matti Viitanen,Paula Summanen	30
16	Detection of the founder effect in Finnish CADASIL families 2004 ·European Journal of Human Genetics ·Kati Mykkänen,Marja‐Liisa Savontaus,Vesa Juvonen,Pertti Sistonen,Seppo Tuisku,Susanna Tuominen,Maila Penttinen,Johan Lundkvist,Matti Viitanen,Hannu Kalimo,Minna Pöyhönen	43
17	Fibrosis and Stenosis of the Long Penetrating Cerebral Arteries: the Cause of the White Matter Pathology in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy 2004 ·Brain Pathology ·Qing Miao,(unknown),Susanna Tuominen,Minna Pöyhönen,Seppo Tuisku,Matti Viitanen,Hannu Kalimo	114
18	New Function for NF1 Tumor Suppressor 2000 ·Journal of Investigative Dermatology ·Jussi Koivunen,Heli Ylä‐Outinen,(unknown),Seija-Liisa Karvonen,Minna Pöyhönen,Matti Laato,Jaakko Karvonen,Sirkku Peltonen,Juha Peltonen	29
19	Occult Neurofibroma and Increased S100 Protein in the Skin of Patients With Neurofibromatosis Type 1 2000 ·Archives of Dermatology ·Seija-Liisa Karvonen,Matti Kallioinen,Heli Ylä‐Outinen,Minna Pöyhönen,Aarne Oikarinen,Juha Peltonen	22
20	A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1 1998 ·Nature Medicine ·Richard Crook,Auli Verkkoniemi,Jordi Pérez‐Tur,Nitin D. Mehta,Matt Baker,Henry Houlden,Matthew J. Farrer,Mike Hutton,Sarah Lincoln,John Hardy,Katrina Gwinn,Mirja Somer,Anders Paetau,Hannu Kalimo,Raija Ylikoski,Minna Pöyhönen,Steve Kucera,Matti Haltia	265

About Minna Pöyhönen

Minna Pöyhönen is a scholar working on Neurology, Immunology and Allergy and Rheumatology, having authored 76 papers that have together received 3.7k indexed citations. Recurring topics across this work include Cerebrovascular and genetic disorders (23 papers), Neurofibromatosis and Schwannoma Cases (23 papers) and Cell Adhesion Molecules Research (10 papers). The work is most often cited by research in Neurology (2.3k citations), Neurology (445 citations) and Rheumatology (783 citations). Minna Pöyhönen has collaborated with scholars based in Finland, Sweden and United States. Frequent co-authors include Hannu Kalimo, Matti Viitanen, Juha Peltonen, Liisa Myllykangas, Petra Pasanen, Anders Paetau, Sirkku Peltonen, Maija Siitonen, Roope A. Kallionpää and Elina Uusitalo. Their work appears in journals such as Nature Medicine, Journal of Clinical Oncology and Brain.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact